Updated:
Keyin Fund
Zheng Wei founded Shanghai-based Keyin Fund in 2017 to deploy concentrated enterprise tech and healthcare bets across China.
Keyin Fund
Zheng Wei established Keyin Fund in 2017, transitioning from a senior role at CITIC Capital's TMT practice to build an independent private equity platform. The firm manages capital from Chinese institutional investors alongside offshore limited partners, though it has not publicly disclosed its aggregate assets under management. Wei structured the firm around a core investment team supplemented by a network of sector-specific operating partners, a model designed to provide portfolio companies with direct operational support beyond board-level governance. Keyin Fund pursues a dual-strategy mandate spanning venture capital and growth equity, with demonstrated activity from seed-stage technology deals through pre-IPO rounds. The portfolio concentrates on enterprise software, industrial technology, and healthcare services, reflecting China's domestic policy priorities around supply-chain modernization and digital infrastructure. Known positions include data middleware provider Taosdata and semiconductor design tools developer X-Epic, alongside undisclosed investments in medical-device and diagnostics platforms. Geographically, the firm originates deals primarily in the Yangtze River Delta and Beijing-Tianjin-Hebei corridors, with select exposure to Shenzhen's hardware ecosystem. Transaction structures include both direct equity and co-investment participation alongside larger domestic GPs. The firm operates from a single office in Shanghai with a lean team, consistent with Wei's stated preference for concentrated portfolio construction over volume-driven deployment. Keyin Fund has not launched publicly announced parallel vehicles such as sector-specific funds or philanthropic foundations. In June 2023, the firm participated in a Series B extension for X-Epic, a chip-design software company, alongside a syndicate of state-backed investors, reinforcing a pattern of co-investing alongside policy-aligned capital pools. Keyin Fund's structural distinction lies in its operating-partner density relative to its compact team size — a deliberate trade-off that substitutes formal portfolio-services headcount with embedded industry veterans. This architecture reflects a broader shift among China-focused mid-market managers toward operational value creation, as pure financial engineering faces tighter regulatory scrutiny. The firm itself remains unregistered with the SEC and does not maintain a US presence, making its dollar-denominated pools accessible almost exclusively to Asia-based qualified institutional buyers.
General information
Firm type
Private Equity
Year founded
2017
AUM
Undisclosed
Location
Region
Asia
Country
China
City
Shanghai
Corporate office
Shanghai, China
Sector focus
Frequently asked questions
Who runs investment decisions at Keyin Fund?
Founder Zheng Wei leads the investment committee and sets the firm's sector strategy, drawing on his prior tenure as a TMT investment lead at CITIC Capital. The firm has not publicly named additional general partners, and investment decisions are understood to be made by a compact internal committee that includes Wei and senior investment directors. The operating-partner network advises on diligence and portfolio management but does not hold formal voting authority.
How does Keyin Fund source proprietary deal flow?
The firm relies on Zheng Wei's relationships across China's venture ecosystem, cultivated during his CITIC Capital years, combined with the deal origination networks of its sector-focused operating partners. Keyin Fund also participates in syndicates with state-backed funds, which provides access to policy-aligned technology and healthcare companies that may not run broad fundraising processes. The firm does not maintain a formal university or incubator partnership program.
Does Keyin Fund participate in fund commitments or only direct deals?
Keyin Fund executes direct equity investments and co-investments; there is no public evidence of a fund-of-funds allocation program or participation as an LP in external managers' vehicles. The firm's disclosed activity — including its role in X-Epic's 2023 Series B extension — is consistent with a direct-investment mandate across both venture and growth equity.
What investment stages does Keyin Fund target?
The firm invests from seed stage through pre-IPO, with particular density in Series A through growth equity rounds for enterprise-software and industrial-technology companies. Healthcare allocations span later-stage medical-device and diagnostics platforms. The dual RMB- and USD-denominated capital base allows Keyin Fund to back companies seeking either a domestic A-share listing or an offshore exit.
Which sectors does Keyin Fund explicitly avoid?
There is no public statement of sector exclusions, but the portfolio's observed absence of consumer-internet, gaming, and real-estate positions suggests a deliberate focus on enterprise-facing and regulated industrial sectors. The firm also shows no exposure to cryptocurrency, blockchain infrastructure, or carbon-credit markets.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: